This is a $720,000 labor hours purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, to Ml_Consult LLC, a for-profit limited liability company, to provide therapeutic oligonucleotide platform biologics chemistry, manufacturing and controls (CMC) subject matter expert consulting services. The services are in support of NINDS's Ultra-Rare Gene Therapy program, the NIH Blueprint Neurotherapeutics Biologics program, and other programs requiring therapeutic oligonucleotide expertise. The contract was awarded on October 16, 2023 and has an ultimate completion date of October 15, 2026. This contract was not set aside for any particular business size or socioeconomic status.
Generated 10/17/24, 9:18 AM